In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Other Products: Pink Sheet | Medtech Insight | HBW Insight | Scrip | Generics Bulletin

Sign In

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Existing Subscriber? Sign in to continue reading.

New to In Vivo? Start a free trial today!

Email
Share

Weston Medical Group PLC

http://www.westonmedical.co.uk

Already a Biomedtracker subscriber? You have access to the full company record through your subscription

Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Zogenix receives US approval for subcutanous needle-free sumatriptan

Bookmark

17 Jul 2009

By John Davis

Zogenix's needle-free, single-use, subcutaneous migraine product, Sumavel DosePro (sumatriptan), has been approved for marketing in the US.

Neurology Approvals

See All

Company Information

Industry
Medical Devices

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Weston Medical Group PLC

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice